Related references
Note: Only part of the references are listed.A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype
Hafeez S. Haniff et al.
CELL CHEMICAL BIOLOGY (2022)
First small-molecule drug targeting RNA gains momentum
Cormac Sheridan
NATURE BIOTECHNOLOGY (2021)
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Fran Supek et al.
TRENDS IN GENETICS (2021)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX-02 in Healthy Subjects
Andi Leubitz et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Riboswitches as Drug Targets for Antibiotics
Vipul Panchal et al.
ANTIBIOTICS-BASEL (2021)
Recent advances in the development of small molecules targeting RNA G-quadruplexes for drug discovery
Yanfei Tao et al.
BIOORGANIC CHEMISTRY (2021)
Ribosome-targeting antibacterial agents: Advances, challenges, and opportunities
Laiying Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Risdiplam in Type 1 Spinal Muscular Atrophy
Giovanni Baranello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Nonsense suppression therapies in human genetic diseases
Patricia Martins-Dias et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays
Zhichao Tang et al.
MOLECULES (2021)
Hunting for human ribozymes
Claire C. Chen et al.
NATURE CHEMICAL BIOLOGY (2021)
Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment
Peiyuan Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique B. Alabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Targeting unfolded protein response: a new horizon for disease control
Madhu Khanna et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)
An omics perspective on drug target discovery platforms
Jussi Paananen et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space
Noreen F. Rizvi et al.
SLAS DISCOVERY (2020)
Structure-Specific Cleavage of an RNA Repeat Expansion with a Dimeric Small Molecule Is Advantageous over Sequence-Specific Recognition by an Oligonucleotide
Raphael Benhamou et al.
ACS CHEMICAL BIOLOGY (2020)
The challenge and prospect of mRNA therapeutics landscape
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2020)
Proteolysis-targeting chimeras in drug development: A safety perspective
Kevin Moreau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Translational read-through promotes aggregation and shapes stop codon identity
Lior Kramarski et al.
NUCLEIC ACIDS RESEARCH (2020)
Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer
Matthew G. Costales et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA
Peiyuan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
Eugenio Mercuri et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
NLRP3 Inflammasome-A Key Player in Antiviral Responses
Chunyuan Zhao et al.
FRONTIERS IN IMMUNOLOGY (2020)
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
Daniel K. Crawford et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
Nonsense-Mediated mRNA Decay: Pathologies and the Potential for Novel Therapeutics
Kamila Pawlicka et al.
CANCERS (2020)
Target-Directed Approaches for Screening Small Molecules against RNA Targets
Hafeez S. Haniff et al.
SLAS DISCOVERY (2020)
Progress toward the development of the small molecule equivalent of small interfering RNA
Matthew D. Disney et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
Bahar Javdan et al.
CELL (2020)
FMRP promotes RNA localization to neuronal projections through interactions between its RGG domain and G-quadruplex RNA sequences
Raeann Goering et al.
ELIFE (2020)
MicroRNAs: From Mechanism to Organism
Philipp J. Dexheimer et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
PEARL-seq: A Photoaffinity Platform for the Analysis of Small Molecule-RNA Interactions
Herschel Mukherjee et al.
ACS CHEMICAL BIOLOGY (2020)
ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease
Eitan Kerem
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions
Hafeez S. Haniff et al.
NATURE CHEMISTRY (2020)
A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
Salima Daou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy
Shiori Ando et al.
SCIENTIFIC REPORTS (2020)
Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders
Hafeez S. Haniff et al.
ACS CENTRAL SCIENCE (2020)
A general fragment-based approach to identify and optimize bioactive ligands targeting RNA
Blessy M. Suresh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Therapeutic siRNA: state of the art
Bo Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies
Siddhartha Bhatt et al.
TOXICOLOGICAL SCIENCES (2019)
Engineered transfer RNAs for suppression of premature termination codons
John D. Lueck et al.
NATURE COMMUNICATIONS (2019)
Targeted design and identification of AC1NOD4Q to block activity of HOTAIR by abrogating the scaffold interaction with EZH2
Yu Ren et al.
CLINICAL EPIGENETICS (2019)
RNA Biology Provides New Therapeutic Targets for Human Disease
Lorna W. Harries
FRONTIERS IN GENETICS (2019)
RNA Chemistry o RNA Biology
Pascal Rothlisberger et al.
CHIMIA (2019)
Using SHAPE-MaP to probe small molecule-RNA interactions
Sarah Martin et al.
METHODS (2019)
A cross-linking approach to map small molecule-RNA binding sites in cells
Sai Pradeep Velagapudi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
HOX transcript antisense RNA (HOTAIR) in cancer
Xiaohan Qu et al.
CANCER LETTERS (2019)
The diverse structural landscape of quadruplexes
Helen L. Lightfoot et al.
FEBS LETTERS (2019)
Safety screening in early drug discovery: An optimized assay panel
Stefanie Bendels et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Riboswitch distribution, structure, and function in bacteria
Nikolet Pavlova et al.
GENE (2019)
R-BIND: An Interactive Database for Exploring and Developing RNA Targeted Chemical Probes
Brittany S. Morgan et al.
ACS CHEMICAL BIOLOGY (2019)
Selective Small-Molecule Targeting of a Triple Helix Encoded by the Long Noncoding RNA, MALAT1
Fardokht A. Abulwerdi et al.
ACS CHEMICAL BIOLOGY (2019)
The evolution of RNA structural probing methods: From gels to next-generation sequencing
Elodie Mailler et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2019)
Caffeine boosts Ataluren's readthrough activity
Laura Lentini et al.
HELIYON (2019)
Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA
Matthew G. Costales et al.
CELL CHEMICAL BIOLOGY (2019)
The Natural Product Butylcycloheptyl Prodiginine Binds Pre-miR-21, Inhibits Dicer-Mediated Processing of Pre-miR-21, and Blocks Cellular Proliferation
Joe S. Matarlo et al.
CELL CHEMICAL BIOLOGY (2019)
Development and Implementation of an HTS-Compatible Assay for the Discovery of Selective Small-Molecule Ligands for Pre-microRNAs
Daniel A. Lorenz et al.
SLAS DISCOVERY (2018)
Discovery of Selective RNA-Binding Small Molecules by Affinity Selection Mass Spectrometry
Noreen F. Rizvi et al.
ACS CHEMICAL BIOLOGY (2018)
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
Nicola Amodio et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Small Molecule Targeted Recruitment of a Nuclease to RNA
Matthew G. Costales et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Expansion of cat-ELCCA for the Discovery of Small Molecule Inhibitors of the Pre-let-7-Lin28 RNA-Protein Interaction
Daniel A. Lorenz et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Amparo Garcia-Lopez et al.
NATURE COMMUNICATIONS (2018)
Modulation of oncogenic miRNA biogenesis using functionalized polyamines
Cathy Staedel et al.
SCIENTIFIC REPORTS (2018)
Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold
Anita Donlic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Small synthetic molecule-stabilized RNA pseudoknot as an activator for-1 ribosomal frameshifting
Saki Matsumoto et al.
NUCLEIC ACIDS RESEARCH (2018)
Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma
Ryan L. Setten et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs
Sai Pradeep Velagapudi et al.
CELL CHEMICAL BIOLOGY (2018)
Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays
Colleen M. Connelly et al.
ACS CHEMICAL BIOLOGY (2017)
Posttranscriptional chemical labeling of RNA by using bioorthogonal chemistry
Jerrin Thomas George et al.
METHODS (2017)
PhenDV, a turn-off fluorescent quadruplex DNA probe for improving the sensitivity of drug screening assays
Claire Beauvineau et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Clinical chemoproteomics - Opportunities and obstacles
Lyn H. Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm
Lyn Rosenbrier Ribeiro et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Towards the Prevention of Aminoglycoside-Related Hearing Loss
Mary E. O'Sullivan et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
Manaswini Sivaramakrishnan et al.
NATURE COMMUNICATIONS (2017)
Potential functional and pathological side effects related to off-target pharmacological activity
James J. Lynch et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
Nathanael G. Lintner et al.
PLOS BIOLOGY (2017)
Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs
Matthew D. Disney et al.
ACS CHEMICAL BIOLOGY (2016)
Secondary pharmacology: screening and interpretation of off-target activities - focus on translation
Steven Whitebread et al.
DRUG DISCOVERY TODAY (2016)
A Small Molecule That Represses Translation of G-Quadruplex-Containing mRNA
Yousuke Katsuda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects
Christina Backes et al.
MOLECULAR DIAGNOSIS & THERAPY (2016)
Design of a small molecule against an oncogenic noncoding RNA
Sai Pradeep Velagapudi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E-coli FMN riboswitch
John A. Howe et al.
RNA BIOLOGY (2016)
Impacts of Gut Bacteria on Human Health and Diseases
Yu-Jie Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Selective small-molecule inhibition of an RNA structural element
John A. Howe et al.
NATURE (2015)
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
James Palacino et al.
NATURE CHEMICAL BIOLOGY (2015)
Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective
Thomas Papoian et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen
Roya Pedram Fatemi et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Therapeutics Based on Stop Codon Readthrough
Kim M. Keeling et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15 (2014)
Bottom-up Design of Small Molecules that Stimulate Exon 10 Skipping in Mutant MAPT Pre-mRNA
Yiling Luo et al.
CHEMBIOCHEM (2014)
Predictive in silico off- target profiling in drug discovery
Friedemann Schmidt et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Identification of Biologically Active, HIV TAR RNA-Binding Small Molecules Using Small Molecule Microarrays
Joanna Sztuba-Solinska et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Nonsense-mediated decay in genetic disease: Friend or foe?
Jake N. Miller et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2014)
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Nikolai A. Naryshkin et al.
SCIENCE (2014)
Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: Promises and challenges
V. De Guire et al.
CLINICAL BIOCHEMISTRY (2013)
Targeting the unfolded protein response in disease
Claudio Hetz et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
On the origins of drug polypharmacology
Xavier Jalencas et al.
MEDCHEMCOMM (2013)
Rethinking Molecular Similarity: Comparing Compounds on the Basis of Biological Activity
Faula M. Petrone et al.
ACS CHEMICAL BIOLOGY (2012)
Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly
Jing Ai et al.
CARDIOVASCULAR RESEARCH (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Reporter assays for studying quadruplex nucleic acids
Kangkan Halder et al.
METHODS (2012)
Rescue of nonsense mutations by amlexanox in human cells
Sara Gonzalez-Hilarion et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Pharmaceutical therapies to recode nonsense mutations in inherited diseases
Hui-Ling Rose Lee et al.
PHARMACOLOGY & THERAPEUTICS (2012)
G-quadruplex RNA structure as a signal for neurite mRNA targeting
Murugan Subramanian et al.
EMBO REPORTS (2011)
Molecular Mechanisms of Long Noncoding RNAs
Kevin C. Wang et al.
MOLECULAR CELL (2011)
Chemical RNA Modifications for Studies of RNA Structure and Dynamics
Falk Wachowius et al.
CHEMBIOCHEM (2010)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe
Annette Lasham et al.
NUCLEIC ACIDS RESEARCH (2010)
Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
Andrew Prayle et al.
THORAX (2010)
Long noncoding RNAs in mammalian cells: what, where, and why?
Ling-Ling Chen et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2010)
RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth
W. Al-Ahmadi et al.
ONCOGENE (2009)
Targeting RNA with small molecules
Jason R. Thomas et al.
CHEMICAL REVIEWS (2008)
A meta-analysis of nonsense mutations causing human genetic disease
Matthew Mort et al.
HUMAN MUTATION (2008)
Displacement of protein-bound aptamers with small molecules screened by fluorescence polarization
Markus Hafner et al.
NATURE PROTOCOLS (2008)
Germline Mutation in RNASEL Predicts Increased Risk of Head and Neck, Uterine Cervix and Breast Cancer
Bo Eskerod Madsen et al.
PLOS ONE (2008)
Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L
Christopher L. Washenberger et al.
VIRUS RESEARCH (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
Small-molecule activators of RNase L with broad-spectrum antiviral activity
Chandar S. Thakur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions
Lance M. Hellman et al.
NATURE PROTOCOLS (2007)
Development of a fluorescent intercalator displacement assay (G4-FID) for establishing quadruplex-DNA affinity and selectivity of putative ligands
David Monchaud et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Are splicing mutations the most frequent cause of hereditary disease?
N López-Bigas et al.
FEBS LETTERS (2005)
Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA
LP Yu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Implications for RNase L in prostate cancer biology
RH Silverman
BIOCHEMISTRY (2003)
Share Paper
